BioAffinity Technologies Announces Secondary Offering of 1.8M Shares
Express News | BioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO
10-Q: Q2 2024 Earnings Report
Express News | BioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing Cypath® Lung Sales
Express News | BioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
Express News | BioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million